Literature DB >> 35476593

Nonlesional lupus skin contributes to inflammatory education of myeloid cells and primes for cutaneous inflammation.

Allison C Billi1, Feiyang Ma2,3, Olesya Plazyo1, Mehrnaz Gharaee-Kermani1,3, Rachael Wasikowski1, Grace A Hile1, Xianying Xing1, Christine M Yee4, Syed M Rizvi4, Mitra P Maz3, Celine C Berthier5, Fei Wen4, Lam C Tsoi1, Matteo Pellegrini2, Robert L Modlin2, Johann E Gudjonsson1, J Michelle Kahlenberg1,3.   

Abstract

Cutaneous lupus erythematosus (CLE) is a disfiguring and poorly understood condition frequently associated with systemic lupus. Previous studies suggest that nonlesional keratinocytes play a role in disease predisposition, but this has not been investigated in a comprehensive manner or in the context of other cell populations. To investigate CLE immunopathogenesis, normal-appearing skin, lesional skin, and circulating immune cells from lupus patients were analyzed via integrated single-cell RNA sequencing and spatial RNA sequencing. We demonstrate that normal-appearing skin of patients with lupus represents a type I interferon-rich, prelesional environment that skews gene transcription in all major skin cell types and markedly distorts predicted cell-cell communication networks. We also show that lupus-enriched CD16+ dendritic cells undergo robust interferon education in the skin, thereby gaining proinflammatory phenotypes. Together, our data provide a comprehensive characterization of lesional and nonlesional skin in lupus and suggest a role for skin education of CD16+ dendritic cells in CLE pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35476593      PMCID: PMC9169615          DOI: 10.1126/scitranslmed.abn2263

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   19.319


  42 in total

1.  Characterization of human blood dendritic cell subsets.

Authors:  Kelli P A MacDonald; David J Munster; Georgina J Clark; Andrzej Dzionek; Juergen Schmitz; Derek N J Hart
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

2.  Cutaneous lupus and the Cutaneous Lupus Erythematosus Disease Area and Severity Index instrument.

Authors:  Rachel S Klein; Pamela A Morganroth; Victoria P Werth
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

3.  The effect of increasing the dose of hydroxychloroquine (HCQ) in patients with refractory cutaneous lupus erythematosus (CLE): An open-label prospective pilot study.

Authors:  François Chasset; Laurent Arnaud; Nathalie Costedoat-Chalumeau; Noel Zahr; Didier Bessis; Camille Francès
Journal:  J Am Acad Dermatol       Date:  2016-02-03       Impact factor: 11.527

4.  Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells.

Authors:  Charles-Antoine Dutertre; Etienne Becht; Sergio Erdal Irac; Ahad Khalilnezhad; Vipin Narang; Shabnam Khalilnezhad; Pei Y Ng; Lucas L van den Hoogen; Jing Yao Leong; Bernett Lee; Marion Chevrier; Xiao Meng Zhang; Pearly Jean Ai Yong; Geraldine Koh; Josephine Lum; Shanshan Wu Howland; Esther Mok; Jinmiao Chen; Anis Larbi; Henry Kun Kiaang Tan; Tony Kiat Hon Lim; Panagiota Karagianni; Athanasios G Tzioufas; Benoit Malleret; Joshua Brody; Salvatore Albani; Joel van Roon; Timothy Radstake; Evan W Newell; Florent Ginhoux
Journal:  Immunity       Date:  2019-08-29       Impact factor: 31.745

5.  Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.

Authors:  Bing Yan; Shuang Ye; Guangjie Chen; Miao Kuang; Nan Shen; Shunle Chen
Journal:  Arthritis Rheum       Date:  2008-03

6.  Fast, sensitive and accurate integration of single-cell data with Harmony.

Authors:  Ilya Korsunsky; Nghia Millard; Jean Fan; Kamil Slowikowski; Fan Zhang; Kevin Wei; Yuriy Baglaenko; Michael Brenner; Po-Ru Loh; Soumya Raychaudhuri
Journal:  Nat Methods       Date:  2019-11-18       Impact factor: 28.547

7.  TNF-α Regulates Human Plasmacytoid Dendritic Cells by Suppressing IFN-α Production and Enhancing T Cell Activation.

Authors:  Antonios Psarras; Agne Antanaviciute; Adewonuola Alase; Ian Carr; Miriam Wittmann; Paul Emery; George C Tsokos; Edward M Vital
Journal:  J Immunol       Date:  2021-01-13       Impact factor: 5.426

Review 8.  Cytokinocytes: the diverse contribution of keratinocytes to immune responses in skin.

Authors:  Yanyun Jiang; Lam C Tsoi; Allison C Billi; Nicole L Ward; Paul W Harms; Chang Zeng; Emanual Maverakis; J Michelle Kahlenberg; Johann E Gudjonsson
Journal:  JCI Insight       Date:  2020-10-15

9.  Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity.

Authors:  Antonios Psarras; Adewonuola Alase; Agne Antanaviciute; Ian M Carr; Md Yuzaiful Md Yusof; Miriam Wittmann; Paul Emery; George C Tsokos; Edward M Vital
Journal:  Nat Commun       Date:  2020-12-01       Impact factor: 17.694

10.  Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesis.

Authors:  Johann E Gudjonsson; Lam C Tsoi; Feiyang Ma; Allison C Billi; K R van Straalen; A R J V Vossen; H H van der Zee; Paul W Harms; Rachael Wasikowski; Christine M Yee; Syed M Rizvi; Xianying Xing; Enze Xing; Olesya Plazyo; Chang Zeng; Matthew T Patrick; Margaret M Lowe; Richard E Burney; Jeffrey H Kozlow; Jill R Cherry-Bukowiec; Yanyun Jiang; Joseph Kirma; Stephan Weidinger; Kelly C Cushing; Michael D Rosenblum; Celine Berthier; Amanda S MacLeod; John J Voorhees; Fei Wen; J Michelle Kahlenberg; Emanual Maverakis; Robert L Modlin; Errol P Prens
Journal:  JCI Insight       Date:  2020-10-02
View more
  2 in total

Review 1.  Emerging concepts of type I interferons in SLE pathogenesis and therapy.

Authors:  Antonios Psarras; Miriam Wittmann; Edward M Vital
Journal:  Nat Rev Rheumatol       Date:  2022-09-12       Impact factor: 32.286

Review 2.  Rapid Response of Refractory Systemic Lupus Erythematosus Skin Manifestations to Anifrolumab-A Case-Based Review of Clinical Trial Data Suggesting a Domain-Based Therapeutic Approach.

Authors:  Marlene Plüß; Silvia Piantoni; Chris Wincup; Peter Korsten
Journal:  J Clin Med       Date:  2022-06-15       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.